|
US7192584B2
(en)
*
|
1991-03-18 |
2007-03-20 |
Centocor, Inc. |
Methods of treating psoriasis with anti-TNF antibodies
|
|
US6355450B1
(en)
|
1995-04-21 |
2002-03-12 |
Human Genome Sciences, Inc. |
Computer readable genomic sequence of Haemophilus influenzae Rd, fragments thereof, and uses thereof
|
|
US20050131222A1
(en)
|
1995-04-21 |
2005-06-16 |
Human Genome Sciences, Inc. |
Nucleotide sequence of the haemophilus influenzae Rd genome, fragments thereof, and uses thereof
|
|
US6551795B1
(en)
|
1998-02-18 |
2003-04-22 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
|
|
US6696550B2
(en)
|
1998-07-23 |
2004-02-24 |
Millennium Pharmaceuticals, Inc. |
Humanized anti-CCR2 antibodies and methods of use therefor
|
|
US6303321B1
(en)
|
1999-02-11 |
2001-10-16 |
North Shore-Long Island Jewish Research Institute |
Methods for diagnosing sepsis
|
|
US20020132753A1
(en)
|
2000-01-31 |
2002-09-19 |
Rosen Craig A. |
Nucleic acids, proteins, and antibodies
|
|
JP2003527439A
(ja)
|
2000-03-17 |
2003-09-16 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
抗ｃｄ１８抗体と抗ｃｃｒ２抗体の混合物を用いる狭窄および再狭窄を抑制する方法
|
|
KR100390332B1
(ko)
|
2000-08-02 |
2003-07-07 |
유원민 |
항말라리아제와 항암제의 병용투여에 의한 항암제 복합 조성물
|
|
AU2002307448A1
(en)
|
2001-04-20 |
2002-11-05 |
President And Fellows Of Harvard College |
Methods and compositions for the modulation of biofilm formation
|
|
WO2004001058A2
(en)
|
2001-05-04 |
2003-12-31 |
Paratek Pharmaceuticals, Inc. |
Transcription factor modulating compounds and methods of use thereof
|
|
CN100447154C
(zh)
|
2001-05-15 |
2008-12-31 |
费因斯坦医学研究学院 |
利用hmg片段作为抗炎症试剂
|
|
AU2002328203C1
(en)
|
2001-08-24 |
2009-01-08 |
Migenix Inc. |
Antimicrobial and anti-inflammatory peptides
|
|
ITMI20011986A1
(it)
|
2001-09-25 |
2003-03-25 |
San Raffaele Centro Fond |
Metodo e composizione per l'attivazione di cellule presentanti l'antigene
|
|
US20030099602A1
(en)
|
2001-10-25 |
2003-05-29 |
Levin Gilbert V. |
D-tagatose as an anti-biofilm agent
|
|
US20060057160A1
(en)
|
2002-08-02 |
2006-03-16 |
Ralph Biemans |
Vaccine composition
|
|
GB0226251D0
(en)
|
2002-11-11 |
2002-12-18 |
San Raffaele Centro Fond |
Acetylated protein
|
|
US20060121047A1
(en)
*
|
2002-11-20 |
2006-06-08 |
Tracey Kevin J |
Use of hmgb polypetides for increasing immune responses
|
|
JP2006510619A
(ja)
*
|
2002-11-20 |
2006-03-30 |
クリティカル セラピューティクス，インコーポレイテッド |
抗炎症剤としてのｈｍｇｂ断片の使用
|
|
US7285269B2
(en)
|
2002-12-02 |
2007-10-23 |
Amgen Fremont, Inc. |
Antibodies directed to tumor necrosis factor
|
|
WO2004061456A2
(de)
|
2003-01-03 |
2004-07-22 |
Alcedo Biotech Gmbh |
Verwendungen von hmgb, hmgn, hmga proteinen
|
|
US7297340B2
(en)
|
2003-01-07 |
2007-11-20 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
|
WO2004072094A2
(en)
|
2003-02-14 |
2004-08-26 |
Fondazione Centro San Raffaele Del Monte Tabor |
Hmgb1 modulator binding domain
|
|
CA2796381A1
(en)
|
2003-03-06 |
2004-09-16 |
Children's Hospital, Inc. |
Genes of an otitis media isolate of nontypeable haemophilus influenzae
|
|
WO2005025604A2
(en)
|
2003-09-10 |
2005-03-24 |
The General Hospital Corporation |
Use of hmgb and hmgb fragments to decrease specific immune response
|
|
US7413868B2
(en)
|
2003-11-05 |
2008-08-19 |
Trellis Bioscience, Inc. |
Use of particulate labels in bioanalyte detection methods
|
|
US20090029929A1
(en)
|
2004-03-26 |
2009-01-29 |
Locomogene, Inc. |
Decoy Nucleic Acid to Synoviolin Gene Promoter
|
|
US8728525B2
(en)
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
|
GB0410866D0
(en)
|
2004-05-14 |
2004-06-16 |
Chiron Srl |
Haemophilius influenzae
|
|
US20080305120A1
(en)
|
2004-06-17 |
2008-12-11 |
Medimmune, Inc. |
Immunogenic Compositions Comprising Hmgb 1 Polypeptides
|
|
EP1799255A4
(en)
|
2004-06-25 |
2008-10-01 |
Medimmune Vaccines Inc |
RECOMBINANT HUMANESE CYTOMEGALOVIRUS AND HETEROLOGIST ANTIGENS CONTAINING VACCINES
|
|
US20060030539A1
(en)
|
2004-08-06 |
2006-02-09 |
National Jewish Medical And Research Center |
Product and process for inhibition of biofilm development
|
|
WO2007001422A2
(en)
|
2004-10-22 |
2007-01-04 |
Medimmune, Inc. |
High affinity antibodies against hmgb1 and methods of use thereof
|
|
SI1858920T1
(sl)
|
2005-02-18 |
2016-07-29 |
Glaxosmithkline Biologicals S.A. |
Proteini in nukleinske kisline iz escherichia coli, povezane z meningitisom/sepso
|
|
US20060228384A1
(en)
|
2005-04-06 |
2006-10-12 |
Sequoia Sciences, Inc. |
Control of biofilm with a biofilm inhibitor
|
|
WO2006114805A2
(en)
|
2005-04-28 |
2006-11-02 |
Fondazione Centro San Raffaele Del Monte Tabor |
Use of hmgb2 and hmgb3 proteins for medical applications
|
|
CA2871088A1
(en)
|
2005-06-16 |
2006-12-28 |
Lauren O. Bakaletz |
Genes of an otitis media isolate of nontypeable haemophilus influenzae
|
|
ATE488526T1
(de)
|
2005-07-08 |
2010-12-15 |
Nationwide Childrens Hospital |
Chimärer impfstoff für haemophilus influenzae- induzierte infektion
|
|
EP1943344A2
(en)
|
2005-10-04 |
2008-07-16 |
The Ludwig Institute for Cancer Research |
Methods for stimulating an immune response using bacterial antigen delivery system
|
|
US20090264342A1
(en)
|
2006-02-13 |
2009-10-22 |
Trustees Of Boston University |
Compositions and methods for antibiotic potentiation and drug discovery
|
|
US20070286822A1
(en)
|
2006-06-12 |
2007-12-13 |
Anacor Pharmaceuticals Inc. |
Compounds for the Treatment of Periodontal Disease
|
|
CA2660668C
(en)
|
2006-08-21 |
2016-06-28 |
The University Of British Columbia |
Small cationic antimicrobial peptides
|
|
CA2663300C
(en)
*
|
2006-09-15 |
2014-10-07 |
Creabilis Therapeutics S.P.A. |
Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1
|
|
EP1980269A1
(en)
|
2007-04-13 |
2008-10-15 |
Katholieke Universiteit Leuven |
Prevention of staphylococcus biofilm formation
|
|
WO2009006699A1
(en)
|
2007-07-12 |
2009-01-15 |
Oral Health Australia Pty Ltd |
Biofilm treatment
|
|
CN103097399A
(zh)
|
2010-03-29 |
2013-05-08 |
南加利福尼亚大学 |
用于去除生物膜的组合物及方法
|
|
EP2613797B1
(en)
|
2010-09-09 |
2015-11-04 |
University Of Southern California |
Compositions and methods for the removal of biofilms
|
|
US9746475B2
(en)
|
2011-03-14 |
2017-08-29 |
University Of Southern California |
Antibody and antibody mimetic for visualization and ablation of endogenous proteins
|
|
WO2012151555A1
(en)
|
2011-05-04 |
2012-11-08 |
President And Fellows Of Harvard College |
Methods and coatings for treating biofilms
|
|
US20130183323A1
(en)
|
2011-12-19 |
2013-07-18 |
Hua Wang |
Targeted antibiotic and antimicrobial treatments for personalized administration
|
|
AU2013266069B2
(en)
|
2012-05-25 |
2018-03-15 |
Sloan Kettering Institute For Cancer Research |
Methods for treating GI syndrome and graft versus host disease
|
|
WO2013181694A1
(en)
|
2012-06-04 |
2013-12-12 |
Gaurav Agrawal |
Compositions and methods for treating crohn's disease and related conditions and infections
|
|
ES2661500T3
(es)
|
2012-07-26 |
2018-04-02 |
Ospedale San Raffaele S.R.L. |
Variantes de HMGB1 y sus usos
|
|
WO2014070769A1
(en)
|
2012-10-29 |
2014-05-08 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for treating mucosal tissue disorders
|
|
RU2694758C2
(ru)
|
2012-12-20 |
2019-07-16 |
Раджив Бхушан |
Антимикробные композиции
|
|
AU2014268565B2
(en)
|
2013-05-22 |
2018-01-18 |
Curza Global, Llc |
Compositions and methods comprising a polyamine
|
|
ES2746971T3
(es)
|
2013-06-13 |
2020-03-09 |
Res Inst Nationwide Childrens Hospital |
Composiciones y procedimientos para el tratamiento de infecciones por burkholderia
|
|
US11274144B2
(en)
|
2013-06-13 |
2022-03-15 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the removal of biofilms
|
|
US20160194384A1
(en)
*
|
2014-06-12 |
2016-07-07 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the removal of biofilms
|
|
US20160289287A1
(en)
|
2013-08-27 |
2016-10-06 |
The University Of British Columbia |
Small cationic anti-biofilm and idr peptides
|
|
US11013858B2
(en)
|
2016-01-12 |
2021-05-25 |
David S. Goldsmith |
Nonjacketing side-entry connectors and prosthetic disorder response systems
|
|
US9745366B2
(en)
|
2013-09-23 |
2017-08-29 |
University Of Southern California |
Compositions and methods for the prevention of microbial infections
|
|
US20150086561A1
(en)
|
2013-09-26 |
2015-03-26 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US10233234B2
(en)
|
2014-01-13 |
2019-03-19 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US20150197558A1
(en)
|
2013-09-26 |
2015-07-16 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US11248040B2
(en)
|
2013-09-26 |
2022-02-15 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US20150299298A1
(en)
|
2013-09-26 |
2015-10-22 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US10624934B2
(en)
|
2014-03-06 |
2020-04-21 |
Research Institute At Nationwide Children's Hospital |
Prebiotic formulations
|
|
CA2941933A1
(en)
|
2014-03-13 |
2015-09-17 |
The Secretary Of State For Health |
Antimicrobial conjugates, method for production and uses thereof
|
|
WO2016154491A1
(en)
|
2015-03-25 |
2016-09-29 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US9801909B2
(en)
|
2015-04-06 |
2017-10-31 |
The Penn State Research Foundation |
Compositions and methods for combating bacterial infections by killing persister cells with mitomycin C
|
|
GB201508337D0
(en)
|
2015-05-15 |
2015-06-24 |
Hmgbiotech S R L |
Novel peptides
|
|
US20160340650A1
(en)
|
2015-05-21 |
2016-11-24 |
Batu Biologics, Inc. |
Blood derived immune stimulatory compositions
|
|
WO2017023863A1
(en)
|
2015-07-31 |
2017-02-09 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
|
EP3365027B1
(en)
|
2015-10-14 |
2022-03-30 |
Research Institute at Nationwide Children's Hospital |
Hu specific antibodies and their use in inhibiting biofilm
|
|
CN109069871A
(zh)
|
2015-12-04 |
2018-12-21 |
加利福尼亚大学董事会 |
用于治疗癌症的新抗体
|
|
US20170182205A1
(en)
|
2015-12-28 |
2017-06-29 |
ProclaRx LLC |
Medical devices with biofilm disruptors
|
|
WO2017192594A1
(en)
|
2016-05-02 |
2017-11-09 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
AU2017319702B2
(en)
|
2016-09-02 |
2024-11-14 |
The Regents Of The University Of California |
Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments
|
|
FR3055801B1
(fr)
|
2016-09-15 |
2020-10-30 |
Virbac |
Derives esters de squalamine pour le traitement des infections
|
|
JP7661008B2
(ja)
|
2017-01-04 |
2025-04-14 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
バイオフィルム関連障害の処置のための抗体断片
|
|
US11564982B2
(en)
|
2017-01-04 |
2023-01-31 |
Research Institute At Nationwide Children's Hospital |
DNABII vaccines and antibodies with enhanced activity
|
|
WO2018170178A1
(en)
*
|
2017-03-15 |
2018-09-20 |
Research Institute At Nationwide Children's Hospital |
Composition and methods for disruption of bacterial biofilms without accompanying inflammation
|
|
CA3058813A1
(en)
|
2017-04-05 |
2018-10-11 |
University Of Utah Research Foundation |
Compositions and methods comprising a triaryl polyamine
|
|
MX2020014006A
(es)
|
2018-06-29 |
2021-05-27 |
Res Inst Nationwide Childrens Hospital |
Composiciones y métodos para mediar la eps.
|
|
EP3841120B1
(en)
|
2018-08-21 |
2025-09-24 |
Citryll B.V. |
Antibodies binding to citrullinated histone 2a and/or 4
|
|
AU2019354829B2
(en)
|
2018-10-05 |
2025-04-17 |
Research Institute At Nationwide Children's Hospital |
Hmgb1 protein derivatives for the removal of biofilms
|
|
AU2019369498A1
(en)
|
2018-10-31 |
2021-05-20 |
Delinia, Inc. |
Multivalent regulatory T cell modulators
|
|
AU2020311897A1
(en)
|
2019-07-08 |
2022-02-03 |
Research Institute At Nationwide Children's Hospital |
Antibody compositions for disrupting biofilms
|